Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.
暂无分享,去创建一个
[1] B. Feldman,et al. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. , 2008, Arthritis and rheumatism.
[2] Yi-Wen Chen,et al. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis , 2008, BMC Immunology.
[3] B. Feldman,et al. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood , 2008, The Lancet.
[4] L. Pachman,et al. Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.
[5] A. Paller,et al. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.
[6] B. Feldman,et al. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). , 2006, Rheumatology.
[7] A. Dyer,et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. , 2006, The Journal of pediatrics.
[8] A. Dyer,et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. , 2005, Arthritis and rheumatism.
[9] A. Dyer,et al. Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. , 2004, The Journal of rheumatology.
[10] P. Bacon,et al. Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study , 2003, Annals of the rheumatic diseases.
[11] R. Bode,et al. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. , 2003, Arthritis and rheumatism.
[12] L. Pachman,et al. Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF alpha-308A allele in children with juvenile dermatomyositis. , 2002, Clinical immunology.
[13] L. Pachman,et al. TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications , 2000 .
[14] H. Maricq,et al. Childhood dermatomyositis: serial microvascular studies. , 1989, Pediatrics.
[15] H. Maricq,et al. Serial changes in nailfold capillary morphology in childhood dermatomyositis. , 1983, Arthritis and rheumatism.
[16] A. Bohan,et al. Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.
[17] A. Bohan,et al. Polymyositis and dermatomyositis (second of two parts). , 1975 .